Moderna's proposed price for a two-dose course sold to governments compares with US$39 for two doses under a deal that Pfizer Inc and German partner BioNTech struck with the U.S. government.
LONDON: Moderna Inc is planning to price its coronavirus vaccine at US$50 to $60 per course, at least $11 more than another vaccine from Pfizer Inc and BioNTech, the Financial Times reported on Tuesday, citing unnamed sources.
Moderna's proposed price for a two-dose course sold to governments compares with US$39 for two doses under a deal that Pfizer Inc and German partner BioNTech struck with the U.S. government.
Already a subscriber? Log in.
Subscribe or renew your subscriptions to win prizes worth up to RM68,000!
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
